-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 18, Tianyao Pharmaceutical issued an announcement stating that its subsidiary Jinyao Pharmaceutical had received the "Drug Supplementary Application Approval Notice" for norepinephrine bitartrate injection approved and issued by the National Medical Products Administration, and approved it The drug passed the quality and efficacy consistency evaluation of generic drugs
Norepinephrine bitartrate injection belongs to the category of "National Essential Drug List (2018)", "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2020)" Category A variety, clinically necessary and easy to shortage drugs
At present, there are 7 companies in the domestic market whose norepinephrine bitartrate injections have been approved for listing.